Skip to main content

GEROSCIENCE-ICFSR2025 Task Force on Pre-Clinical and Clinical Trials

March 12, 2025

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX

“Novel Gerotherapeutic Peptide PTC-2105 Reverses the Aging Phenotype In Naturally Aged Mice”

Task Force on Pre-Clinical and Clinical Trials 2025 – oral communication

2:20 – 2:40 P.M. local time (8:20 – 8:40 A.M. EST)